抗人类免疫缺陷病毒治疗与肝脏疾病：挑战与机遇。
Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities.
机构信息
Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico.
Department of Immunology, Biomedical Research Institute, National Autonomous University of Mexico, Mexico.
出版信息
Ann Hepatol. 2020 Mar-Apr;19(2):121-122. doi: 10.1016/j.aohep.2020.02.004.
The post antiretroviral therapy (ART) era for human immunodeficiency virus (HIV) infection resulted in a dramatically increased proportion of deaths attributed to liver-related causes in patients with HIV treated with ART. Additionally, as patients become older as a result of effective ART, liver-related conditions and application of safe therapies are now major concerns in the setting of HIV infection.
抗逆转录病毒治疗（ART）后时代，人类免疫缺陷病毒（HIV）感染患者接受 ART 治疗后，因肝脏相关原因导致的死亡比例大幅增加。此外，由于有效的 ART 治疗使患者年龄增大，肝脏相关疾病和安全治疗方法的应用成为 HIV 感染背景下的主要关注点。
Zotero 插件